The UK's aging population and changing consumer trends are seeing pharmacies increasingly used as the first port of call for health care and primary care services, says a new report from Verdict Research, part of the Datamonitor Group. These factors and initiatives to move primary health care services out of general practitioner's surgeries and into communities will fuel strong growth in the UK's L12.8 billion ($24.28 billion) retail pharmacy market, as well as ongoing consolidation.
The two main users of pharmacies - the under 14s and the over 65s - are the largest age groups in the population and the 65 plus age group will grow the fastest of any demographic group - one in five people will be 65 plus in 2020. This alone, says Verdict Research, will ensure continual volume growth for prescription dispensing, a major part of pharmacy income.
Furthermore, it says, consumers' propensity for convenience, self-medication and instant treatment, and the willingness to pay for it, plus government policy in using pharmacies to promote good health care and take up the strain on the National Health Service will heighten pharmacy demand further. The new pharmacy contract, and required provision of services and health checks, will make all pharmacies integral in the general health care of the population, but they are also meeting the demands of a society that is constantly mobile and seeks access to health care at any time and in any place
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze